Month: September 2014

Type 2 Diabetes Phase 3 Research Study

  [device] Refer your high-risk cardiovascular patients for study participation today!   An innovative approach to delivering treatment that does not require needles or pills. ITCA 650 (exenatide in DUROS® device) is an...

Read More